Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-08-01

Clinical Trial Update: The Efficacy of Capsaicin Sensitivity Testing in Patients With Irritable Larynx Syndrome

View source ↗

Summary

A clinical trial evaluating capsaicin sensitivity testing for irritable larynx syndrome has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Unity Health Toronto | Conditions: Cough, Larynx | Status: WITHDRAWN